Never has there been a time with greater opportunity to realise long-lasting patient change than currently lies ahead.
The importance of reducing the patient burden, ensuring clinical trials are patient-centric, caring for vulnerable groups and empowering patients has never been greater than now during and after the COVID-19 pandemic.
The last few months have been a turning point for pharma's patient champions. We've seen agility and bravery lead to often successful pivoting towards deeper and more varied digital transformation of engagement strategies and beyond.
At Pharma and Patient Europe, you'll find tangible examples of how the leaders in the industry are enacting long-lasting patient-centric change. We will delve into the core issues pressing the patient-centric movement - demonstrating patient-partnership ROI, reimagining the landscape of engagement post-COVID and using digital to drive innovation in patient services and clinical development.
Let's ensure the new normal is a patient-centric one.